BioLineRx Statistics Share Statistics BioLineRx has 79.86M
shares outstanding. The number of shares has increased by 3562.35%
in one year.
Shares Outstanding 79.86M Shares Change (YoY) 3562.35% Shares Change (QoQ) 2046.1% Owned by Institutions (%) 0% Shares Floating 79.41M Failed to Deliver (FTD) Shares 2,438 FTD / Avg. Volume 0.35%
Short Selling Information The latest short interest is 189.83K, so 5.1% of the outstanding
shares have been sold short.
Short Interest 189.83K Short % of Shares Out 5.1% Short % of Float 5.11% Short Ratio (days to cover) 4.77
Valuation Ratios The PE ratio is -74.15 and the forward
PE ratio is -13.65.
BioLineRx's PEG ratio is
0.84.
PE Ratio -74.15 Forward PE -13.65 PS Ratio 23.63 Forward PS 40.3 PB Ratio 50.79 P/FCF Ratio -15.56 PEG Ratio 0.84
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for BioLineRx.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.76,
with a Debt / Equity ratio of 1.12.
Current Ratio 1.76 Quick Ratio 1.56 Debt / Equity 1.12 Debt / EBITDA 3.84 Debt / FCF -0.34 Interest Coverage -2.25
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.03M Profits Per Employee $-329.32K Employee Count 28 Asset Turnover 0.74 Inventory Turnover 2.95
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -88.39% in the
last 52 weeks. The beta is 0.88, so BioLineRx's
price volatility has been higher than the market average.
Beta 0.88 52-Week Price Change -88.39% 50-Day Moving Average 4.51 200-Day Moving Average 6.34 Relative Strength Index (RSI) 30.28 Average Volume (20 Days) 694,885
Income Statement In the last 12 months, BioLineRx had revenue of 28.94M
and earned -9.22M
in profits. Earnings per share was -0.12.
Revenue 28.94M Gross Profit 19.68M Operating Income -20.41M Net Income -9.22M EBITDA 3.92M EBIT -147K Earnings Per Share (EPS) -0.12
Full Income Statement Balance Sheet The company has 10.44M in cash and 15.04M in
debt, giving a net cash position of -4.6M.
Cash & Cash Equivalents 10.44M Total Debt 15.04M Net Cash -4.6M Retained Earnings -399.83M Total Assets 43.51M Working Capital 17.89M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -43.87M
and capital expenditures -54K, giving a free cash flow of -43.93M.
Operating Cash Flow -43.87M Capital Expenditures -54K Free Cash Flow -43.93M FCF Per Share -0.55
Full Cash Flow Statement Margins Gross margin is 67.99%, with operating and profit margins of -70.52% and -31.86%.
Gross Margin 67.99% Operating Margin -70.52% Pretax Margin -31.86% Profit Margin -31.86% EBITDA Margin 13.54% EBIT Margin -70.52% FCF Margin -151.79%
Dividends & Yields BLRX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for BLRX is $19,
which is 417.7% higher than the current price. The consensus rating is "Buy".
Price Target $19 Price Target Difference 417.7% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 30, 2025. It was a
backward
split with a ratio of 1:40.
Last Split Date Jan 30, 2025 Split Type backward Split Ratio 1:40
Scores Altman Z-Score -3.58 Piotroski F-Score 3
